Tesamorelin + Ipamorelin Blend Research Lab Setup Guide

Setting up a research lab around a tesamorelin and ipamorelin blend comes down to four decisions made in order: where the material originates, how its identity and purity are documented lot by lot, how it is stored and logged once it arrives, and what your own counsel says about your commercial position. Both compounds are research-use-only materials — nothing in this guide is a therapeutic framework, and no dosing, reconstitution, or administration guidance appears here. Most of what determines whether a setup holds up under scrutiny happens at the sourcing stage, long before anything reaches a bench.

For a wholesale buyer — a med spa operator, clinic owner, telehealth founder, or reseller building a catalog — the practical question underneath "lab setup" is usually a procurement question. You are deciding which supplier's documentation you are willing to stand behind.

Two compounds, two mechanisms, one reason they get studied together

Tesamorelin is a synthetic analog of growth hormone-releasing hormone. Ipamorelin is a selective growth hormone secretagogue that research describes as acting at the ghrelin receptor. The reason they appear together in research literature is that they engage the growth hormone axis through different receptor pathways, and studies indicate that distinct upstream mechanisms can produce different signaling profiles than either compound examined alone.

That is the honest extent of it. Published work on growth hormone secretagogues varies widely in model, endpoint, and quality, and anyone selling you a tidy summary of "what the blend does" is selling past the evidence. For a catalog buyer, the useful takeaway is narrower and more actionable: these are two structurally different peptides with different molecular weights, different stability characteristics, and different analytical signatures. That has direct consequences for how a blend is tested and how its paperwork should read.

A certificate of analysis for a single compound is a relatively simple document to interpret. A certificate covering a blend has to resolve two peaks, two identity confirmations, and two purity figures — and the ratio between them. If a supplier hands you a blend COA showing one purity number and no breakdown, you cannot tell which compound that number describes. That is not a technicality. It is the difference between a document you can defend and a document you are hoping nobody reads closely.

Pre-blended vials versus stocking the compounds separately

The blend-versus-single decision shapes your entire documentation burden. Neither option is universally correct, but the trade-offs are predictable.

Most buyers who care about audit quality end up sourcing the compounds as separate, individually tested items and documenting any combination downstream as their own internal process. Real Peptides lists tesamorelin and ipamorelin as separate single-compound catalog items, each with its own batch documentation — which means the purity figure you read belongs unambiguously to the compound named on the label.

Storage, labeling, and the documentation trail

The physical side of a research lab setup for lyophilized peptides is less exotic than people expect, and the parts that matter are mostly about control and records rather than equipment.

Cold storage with monitoring. Lyophilized peptide material is generally handled under cold conditions, and the specific storage condition for any given lot should come from that lot's documentation rather than from a blog post. What matters operationally is that storage is monitored and logged, not just set. A freezer without a temperature record is an assertion, not a control.

Controlled access. Research materials should sit behind restricted access with a log of who removed what and when. This is the single cheapest control to implement and the one most often skipped.

Labeling that survives an audit. Every container should carry the compound name, the lot number, the quantity in milligrams, the date received, and clear research-use-only designation. Lot number is the hinge — if a label and a COA cannot be matched by lot, the COA is decorative.

Inventory reconciliation. Received quantity, current quantity, and disposition should reconcile on demand. Spreadsheets are fine. Gaps are not.

On the question everyone eventually asks: Real Peptides does not provide dosing, reconstitution, or preparation guidance, because these are research-use-only compounds and that guidance would be inappropriate regardless of who asked. The framework that is legitimate to discuss is concentration expressed as milligrams per milliliter — a documentation and labeling concept describing how much compound a given volume of solution contains. Anything past that framework, including volumes, units, or draw amounts, belongs to a qualified researcher's own protocol and not to a supplier's marketing material. Treat any wholesale supplier who volunteers that guidance as a signal about their compliance posture generally.

What to verify before you commit to any supplier

This is where a wholesale relationship is won or lost. The checks below are the ones that separate suppliers who can support a documented operation from suppliers who cannot.

A lot-matched COA you can see before you buy. Not a sample COA. Not a representative COA. The certificate for the lot you will actually receive, matched by number to the vial in your hand. A meaningful share of the industry treats COAs as a paid add-on or a post-purchase request. That practice tells you what you need to know.

HPLC purity with the chromatogram attached. A purity percentage typed into a PDF is a claim. The chromatogram is the evidence. For a growth hormone secretagogue, you want to see a clean dominant peak and a legible baseline, not just a number.

Mass spectrometry identity confirmation. Purity tells you how much of the material is one thing. Mass spec tells you whether that thing is the compound you ordered. Tesamorelin and ipamorelin have very different molecular weights, so identity confirmation is not a formality when blends are in play.

Panel breadth beyond purity. Ask what else is tested per batch — endotoxin, bioburden, heavy metals, residual solvents, water content, and appearance all appear in serious analytical panels. A supplier who tests only purity is testing the one number that markets well.

Published wholesale pricing and stated minimums. Hidden pricing exists to make comparison difficult. If you cannot see tier structure and order minimums without a sales call, you are being managed rather than quoted. Margins and program economics vary widely with volume, category, and your own cost structure, and any supplier quoting you a specific margin figure is guessing on your behalf.

Fulfillment origin and realistic timelines. Where does the order actually ship from, and what is the stated turnaround? Long or vague international transit adds cold-chain risk and customs exposure that a catalog page rarely mentions.

Consistency across reorders. Ask whether COAs are published for every lot or only for the first one. Batch-to-batch consistency is the thing that quietly determines whether your documentation stays coherent six months in.

Regulatory questions to take to your attorney, not your supplier

This section is informational and is not legal advice. The regulatory landscape around research peptides is genuinely unsettled in places, and the right posture is to treat every question below as something you resolve with your own counsel and, where relevant, your state board — not something you resolve by reading a supplier's website.

Questions worth putting in front of qualified counsel include: how research-use-only materials may be held, labeled, and transferred in your jurisdiction and under your specific business license; whether your entity type creates obligations the compound's designation does not; what recordkeeping your state board expects from a business holding research materials; how your marketing language is likely to be read by a regulator; and what documentation you would need to produce on short notice if asked.

No supplier should be telling you that a given activity is permitted in your state. Generally speaking, the answer depends on your license, your entity, your jurisdiction, and facts a vendor does not have. What a supplier legitimately owes you is documentation good enough that your attorney has something real to work with — which loops back to the verification list above.

What Real Peptides does differently

Real Peptides runs its wholesale program on documentation that buyers can check independently rather than take on faith.

Every compound is produced to 99%+ HPLC purity, and each batch runs through a 7-panel test before it is released. COAs are publicly verifiable — the reader can pull up the lab results for a lot and read the chromatogram directly, without asking a sales representative and without paying for the privilege. That is the opposite of the pattern where a certificate arrives after the invoice, or arrives as a generic document with no lot number on it.

Fulfillment is US-based, with orders shipping in 5–7 days, which removes the international transit variable from your inventory planning. Wholesale pricing tiers are stated rather than negotiated behind a call. And the Wholesale Partner Program uses a straightforward 3-step application: submit business information, get reviewed for qualification, and receive tier pricing and catalog access on approval.

All compounds in the catalog, including tesamorelin and ipamorelin, are supplied for research use only and are not FDA-approved drugs.

Bringing a compliant program online

If you have a registered business, a defensible use case, and counsel who has reviewed your position, the practical next step is an application to the Wholesale Partner Program — pull the published COAs for the compounds you are evaluating first, read the chromatograms, and let the documentation decide whether the supplier is worth your catalog space.

Buyers researching this category usually compare Tesamorelin 10mg and Ipamorelin 10mg alongside related secretagogue research materials such as CJC-1295 No DAC 10mg, and the broader growth factor and tissue signaling research collection and popular peptides catalog show how consistently the same testing standard is applied across the line.